Nu Skin: Patience Is Still Advised

Heading into an important year, there is a case on paper for Nu Skin Enterprises ( NUS ) stock. Shares are cheap, trading in the range of 3x adjusted EBITDA for 2026. Guidance for this year does seem to have disappointed, sending shares lower, but marginsI've been contributing to Seeking Alpha and other investment websites since 2011, with a general (though far from rigid) focus on value over growth. I got my Series 7 and 63 back in 1999, and watched the dot-com bubble peak and then burst in real time at a ...